UNCOVERED: Oncology | History Defined

Bristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own Stock

Bristol-Myers Squibb's iza-bren cut breast cancer progression risk by up to 38% in a Phase 3 trial, lifting shares and raising implications for rivals like Exelixis.

MarketBeat · Oct 26

Cencora Agrees to Take Controlling Stake in American Oncology Network in $2.4 Billion Deal Spanning 21 States

Cencora plans to take a controlling stake in American Oncology Network in a deal valued at $2.4 billion. Here is what cancer patients in 21 states should know.

Medical Daily · Oct 24

Why Tumour Marker Tests Sold to Healthy People Create False Alarms

A blood test that promises to detect cancer early sounds like exactly the kind of thing a cautious person should do. Increasingly, diagnostic labs across India are bundling tests for CA-125, PSA, CEA, AFP, and CA 19-9 into routine health packages marketed to people who feel perfectly well. The logic…

Times Life · Oct 24

Tecentriq Plus Chemotherapy Wins Approval for Stage III dMMR Colon Cancer After Halving Recurrence or Death Risk

The FDA approved Tecentriq plus chemotherapy after surgery for stage III dMMR colon cancer after a trial halved the risk of recurrence or death.

Medical Daily · Oct 11

EGFR Lung Cancer Patients Await a November 14 FDA Decision on Ivonescimab Plus Chemotherapy After Tagrisso Stops Working

The FDA is due to decide by Nov. 14 on ivonescimab plus chemotherapy for EGFR lung cancer after Tagrisso. What patients and families can ask now.

Medical Daily · Oct 1

Proton Therapy Did Not Help Advanced Liver Cancer Patients Live Longer Than Standard Radiation in Phase 3 Trial

In the Phase 3 NRG-GI003 trial, proton therapy did not extend survival over standard radiation in advanced liver cancer. Here is what patients should ask.

Medical Daily · Oct 1

Only 3% of Older Cancer Patients with Depression Started Psychotherapy Within Four Weeks of Their Diagnosis

Only 3% of Medicare cancer patients with depression began psychotherapy within four weeks of diagnosis. What the study found and what Medicare covers.

Medical Daily · Sep 29

India needs five-year policy to make precision cancer care afforable, says expert

India needs a five-year roadmap to expand access to genomic testing and targeted cancer therapies for lower-income patients, oncologist Dr Bhawna Sirohi said. A member of the new Lancet Oncology Commission on precision cancer, Sirohi flagged high testing and drug costs and urged their integration into public healthcare schemes.

The Economic Times · Sep 26

Pressure cooker mistake: Doctor says this dangerous habit could be causing more health problems than outside food

Pressure cooker mistake: A pressure cooker’s rubber gasket is often overlooked during routine cleaning, despite regular exposure to steam, moisture and food residue. A social media post by homeopathic oncology practitioner Dr Tarang Krishna has highlighted the importance of removing and cleaning the gasket separately. While some health claims in…

The Economic Times · Sep 23

McKesson Narrows Confirmed Data Theft from Its Cyberattack to Oncology and Multispecialty Customers, Promises Patient Notices

McKesson says confirmed data theft traces mainly to cancer and specialty practice customers. What patients should watch for as notices are prepared.

Medical Daily · Sep 23